Industry

GREENFIELD, Ind.–(BUSINESS WIRE)–Elanco Animal Health Incorporated (NYSE: ELAN) today announced it intends to make concurrent public offerings of 19,159,866 shares of its common stock and 11,000,000 tangible equity units, with an aggregate stated amount of $550 million for the units. Each tangible equity unit has a stated amount of $50 and is composed of (i) … [Read more…]

WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #earnings–Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2019 financial results and provide 2020 guidance on Tuesday, February 11th, before the market opens. A conference call has been scheduled to discuss this information on Tuesday, February 11th, at 8:30 a.m. ET. Investors will have the opportunity to listen … [Read more…]

SAN DIEGO & PENNINGTON, N.J.–(BUSINESS WIRE)–OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, announced today the appointment of Robert J. DelAversano, C.P.A., as OncoSec’s Principal Accounting Officer and Controller, effective as of January 30, 2020. Mr. DelAversano will be responsible for preparation of financial statements, as well … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Global nutrition company Herbalife Nutrition Ltd. (NYSE:HLF) will release its fourth quarter 2019 financial results after the close of trading on the NYSE on Tuesday, February 18, 2020. The same day, at 5:30 p.m. ET (2:30 p.m. PT), the Herbalife Nutrition senior management team will host an investor conference call to discuss its … [Read more…]

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its full-year and fourth-quarter 2019 financial results on Thursday, January 30, 2020 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The conference call … [Read more…]

MANHASSET, N.Y.–(BUSINESS WIRE)–Nearly 1.6 billion people worldwide suffer from anemia, and for the first time new research points to how resistance emerges to the drug dexamethasone used to treat the devastating inherited form of anemia known as Diamond Blackfan anemia (DBA). The Feinstein Institutes for Medical Research professor and expert in disorders of the red … [Read more…]

— First and only FDA-approved medicine for TED, a serious, progressive, vision-threatening rare disease — — Clinical improvements were seen as early as six weeks, with continued improvement across the 24-week treatment period — — Approval comes ahead of the Prescription Drug User Fee Act (PDUFA) goal date of March 8, 2020 — — Horizon … [Read more…]

Egan Jones Recommends FOR Both Harbert Discovery Fund Nominees ISS, Glass Lewis and Egan Jones Have Now All Recommended Shareholders Vote on HDF’s BLUE Card Leading Independent Advisory Firms Have Unanimously Supported the Case for Change Laid out by HDF and Highlighted Enzo’s String of Broken Promises Egan Jones Highlights that Enzo has had Sufficient … [Read more…]

National agreement to support purchasing of quality products NEW HOPE, Pa.–(BUSINESS WIRE)–#cancer–VerdePharmHealth and Base One Health today announced a national group purchasing agreement for procurement of cannabis products across the multi-specialty network. Both organizations aim to simplify the supply chain, lower costs, and provide broad access to meet the needs of the providers and patients … [Read more…]

PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE:PPG) today announced initiatives to support Australian bushfire relief efforts. The company will donate $50,000 USD ($72,432 AUD) to the Australian Red Cross to assist with emergency relief efforts. PPG has also committed to matching employee donations up to $25,000 USD ($36,193 AUD) for a total contribution of $75,000 USD ($108,625 AUD). Locally, … [Read more…]